FindTrial
Sign In

A study of the prevalence of Metabolic syndrome in patients with COPD and its relation to Exacerbations, Lung function and Quality of life

A study of the prevalence of Metabolic syndrome in patients with COPD and its relation to Exacerbations, Lung function and Quality of life - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2025/04/085444
Enrollment
62
Registered
2025-04-23
Start date
Unknown
Completion date
Unknown
Last updated
2025-04-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: J449- Chronic obstructive pulmonary disease, unspecified

Interventions

Intervention1: NIL: NIL

Sponsors

DR TMA PAI HOSPITAL
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: age more than 40years patients with diagnosis of COPD

Exclusion criteria

Exclusion criteria: Acute infections on chronic oxygen therapy on steroid therapy

Design outcomes

Primary

MeasureTime frame
metabolic syndrome more prevalent in obese patients than healthy individuals, hence results will be used to correlate association of COPD and metabolic syndrome henceforth to have lifestyle modificationsTimepoint: At 6 months and 12 months interval metabolic syndrome prevalence in obese patients and healthy individuals, hence results will be used to correlate association of COPD and metabolic syndrome henceforth to have lifestyle modifications—

Secondary

MeasureTime frame
association of COPD and metabolic syndromeTimepoint: 18 months—

Countries

India

Contacts

Public ContactDR SHASHIKIRAN UMAKANTH

DR TMA PAI HOSPITAL

shashikiran.u@manipal.edu9008418171

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026